Two thirds of people diagnosed with Alzheimer’s are women. In addition, research shows that Alzheimer’s biomarker tau protein accumulates differently and more quickly in women’s brains. Researchers like Rosalind Franklin University’s Lise Eliot are investigating how differences in brain structure for men and women are impacting Alzheimer’s risk. Eliot joins Being Patient Live Talks to discuss these gender differences in the brain and the current research in this space.

Former neuroscience nurse practitioner and Alzheimer’s advocate Doreen Monks joins Being Patient Live Talks to discuss her experience with diagnosis and her path toward advocacy.

Sarah Widmeyer joins Being Patient Live Talks to discuss her experience caring for her mother, Elaine, who passed away from Alzheimer’s in 2022, and how the experience set her off on the path to advocating for more gender diversity in clinical research. Widmeyer is an SVP of Wealth Strategies and CMO at Richardson Wealth, and she’s passionate about improving research and access to care for women. The end goal: to improve outcomes for women like her mom.

Pediatric psychotherapist Amanda Sullivan joins Being Patient Live Talks to discuss Leaf, a children’s book that commemorates the life of her mother, who died of frontotemporal dementia (FTD) in 2022. Sullivan wrote the book after struggling to find any children’s books on FTD for her own children.

Brain health researchers are exploring new ways to leverage AI in the diagnosis of diseases like Alzheimer’s. One emerging field of study is that of vocal biomarkers: the way our voices sound. Some companies are even developing personal smart devices to identify vocal biomarkers — and, perhaps one day in the future, to aid in early diagnosis or even disease prevention.

High-tech treatments for neurodegenerative diseases are on the horizon. In fact, some patients already have brain implants that help address their symptoms through “reprogramming the brain.” Hear from one patient and his doctor about the real-life story behind this innovative new treatment for Parkinson’s.

In this live-streamed Q&A with Positive Approach to Care founder and dementia care expert Teepa Snow, she answered Being Patient readers’ questions in real-time.

Alzheimer’s educator and activist Rebecca Chopp, Ph.D., joins Being Patient Live talks to discuss her upcoming book “Still Me: Accepting Alzheimer’s Without Losing Yourself.” As she discussed in a previous live talk with us, she’ll also be speaking about how she defies the stigma of Alzheimer’s by living with joy.

Dr. Ifrah Zawar joins Being Patient Live Talks to discuss seizures, cognitive decline, and dementia. As she discussed in our article on seizures, epilepsy can accelerate cognitive decline, and the condition can also be mistaken for cognitive decline.

Lou Niles joins Being Patient Live Talks to discuss his experience taking part in the donanemab clinical trial. The monoclonal antibody drug was revealed to have promising results in late 2023 and is currently awaiting FDA approval.